(Q53236761)

English

The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic cancer.

scientific article published on 29 May 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic cancer. (English)

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

0 references

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

Srinivasa P. Pothula

2

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

7

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

Jeremy S. Wilson

8

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

Mishaal B Patel

1

object named as

Mishaal B Patel

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

author name string

Zhihong Xu

3

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

Alexandra K Lee

4

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

David Goldstein

5

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

Romano C Pirola

6

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

language of work or name

0 references

publication date

29 May 2014

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

35

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

8

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

1891-1900

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

Epidemiology of pancreatic cancer: an update

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

The epidemiology of pancreatitis and pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Epidemiology, risk factors, and the promotion of pancreatic cancer: role of the stellate cell

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Growth factor signaling in metastasis: current understanding and future opportunities

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

The stromal compartments in pancreatic cancer: are there any therapeutic targets?

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Pancreatic stellate cells: partners in crime with pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Role of pancreatic stellate cells in pancreatic cancer metastasis.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Transforming growth factor-α activates pancreatic stellate cells and may be involved in matrix metalloproteinase-1 upregulation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

A starring role for stellate cells in the pancreatic cancer microenvironment

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor/c-met and STAT3

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Pancreatic stellate cell migration: role of the phosphatidylinositol 3-kinase(PI3-kinase) pathway.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Hepatocyte growth factor twenty years on: Much more than a growth factor

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Scatter factor induces blood vessel formation in vivo

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Hepatocyte growth factor increases vascular endothelial growth factor-A production in human synovial fibroblasts through c-Met receptor pathway

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

uPA and MMP-2 were involved in self-assembled network formation in a two dimensional co-culture model of bone marrow stromal cells and endothelial cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Amplification of the urokinase-type plasminogen activator receptor (uPAR) gene in ductal pancreatic carcinomas identifies a clinically high-risk group

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Identification, culture, and characterization of pancreatic stellate cells in rats and humans.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Biochemical characterization of AMG 102: a neutralizing, fully human monoclonal antibody to human and nonhuman primate hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Ganglioside GM3 promotes HGF-stimulated motility of murine hepatoma cell through enhanced phosphorylation of cMet at specific tyrosine sites and PI3K/Akt-mediated migration signaling

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Anoikis molecular pathways and its role in cancer progression

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Induction of epithelial tubules by growth factor HGF depends on the STAT pathway

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Sunitinib malate for the treatment of pancreas malignancies--where does it fit?

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Normalization of the vasculature for treatment of cancer and other diseases

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategies

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU122

21 January 2018

Identifiers

10.1093/CARCIN/BGU122

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/24876152

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53236761&oldid=1738915851"